Additive/synergistic antitumoral effects on prostate cancer cells in vitro following treatment with a combination of docetaxel and zoledronic acid

By Ullén Anders   Lennartsson Lena   Harmenberg Ulrika   Hjelm-Eriksson Marie   Kälkner Karl Mikael   Lennernäs Bo   Nilsson Sten  

Acta Oncologica, Vol. 44, Iss. 6, 2005-09 ,pp. : 644-650

Informa Healthcare

Access to resources Recommend Favorite

The in vitro anti-tumour activity of zoledronic acid and docetaxel at clinically achievable concentrations in prostate cancer

By Morgan Claire   Lewis Paul D.   Jones Rachel M.   Bertelli Gianfilippo   Thomas Gerry A.   Leonard Robert C. F.  

Acta Oncologica, Vol. 46, Iss. 5, 2007-01 ,pp. : 669-677

Informa Healthcare

Access to resources Recommend Favorite

Possible anti-tumor activity of initial treatment with zoledronic acid with hormonal therapy for bone-metastatic prostate cancer in multicenter clinical trial

By Uemura Hiroji  

International Journal of Clinical Oncology, Vol. 18, Iss. 3, 2013-06 ,pp. : 472-477

Springer Publishing Company

Access to resources Recommend Favorite

Synergistic effects of valproic acid and arsenic trioxide on RPMI8226 cells in vitro and the possible underlying mechanisms

By    

Molecular Medicine Reports, Vol. 12, Iss. 1, 2015-01 ,pp. : 1449-1456

Spandidos Publications

Access to resources Recommend Favorite

Cisplatin in combination with zoledronic acid: A synergistic effect in triple-negative breast cancer cell lines

By                

International Journal of Oncology, Vol. 42, Iss. 4, 2013-01 ,pp. : 1263-1270

Spandidos Publications

Access to resources Recommend Favorite